arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

West Pharmaceutical Services, Inc.

WST Health Care Medical/Dental Instruments
$339.97
Today
as of Sep 4, 16:56 ET
Last 30 days +2.63% Jul 27 → Sep 04
$329.42 $336.04 $342.66 $349.28 $355.90 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$339.76
High
$342.66
Low
$339.77
Volume
$337,806
Avg Vol
$794,030
Mkt Cap
$23.9B
P/E (TTM)
56.34
Beta
—
52w High
$386.00
52w Low
$223.83
Div Yield
—
Shares Out
$70M

Recent Press Releases & News last 60 days · 25 items

Sep 5 · 02:13 Simply Wall St.
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap
Aug 27 · 13:58 Barchart
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink?
Aug 26 · 20:00 PR PR Newswire
West to Participate in Upcoming Investor Conferences
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$224
$386
72% of range
Avg surprise (last 2)
+20.4%
Avg reaction (last 2)
+9.7%
50% positive
Latest IV / EM
23%
EM ±3.6% · $340 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.22$1.45$1.69$1.92$2.15 Actual $1.85Actual $2.06Actual $2.14Actual $1.55Actual $1.51Actual $1.85Actual $1.45Est $1.22Actual $1.84Est $1.51Actual $1.92Actual $1.92Actual $2.15 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$229M$458M$687M$916M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.15 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.92 — — — — financials
Tue Sep 30, 2025Sep 2025 $1.92 — — — — financials
Thu Jul 24, 2025Jun/2025 $1.84 $1.51 +21.9% — +22.8% earnings
Thu Apr 24, 2025Mar/2025 $1.45 $1.22 +18.9% — -3.5% earnings
Mon Sep 30, 2024Sep 2024 $1.85 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.51 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.55 — — — — financials
Sat Sep 30, 2023Sep 2023 $2.14 — — — — financials
Fri Jun 30, 2023Jun 2023 $2.06 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.85 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$872M$845M—$805M$766M$698M—$747M
Cost of revenue$543M$548M—$510M$493M$466M—$482M
Gross profit$329M$296M—$294M$274M$232M—$265M
Operating income$179M$177M—$168M$154M$107M—$161M
Net income$154M$139M—$140M$132M$90M—$136M
EPS (diluted)$2.15$1.92—$1.92$1.82$1.23—$1.85

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$436M$521M$791M$628M$510M$404M$485M$491M
Inventory$447M$453M$444M$438M$421M$389M$377M$401M
Total current assets$1.81B$1.83B$1.98B$1.82B$1.68B$1.46B$1.54B$1.55B
Total assets$4.08B$4.11B$4.27B$4.11B$3.95B$3.62B$3.64B$3.68B
Long-term debt$203M$203M$203M$203M$203M$203M$203M$203M
Total liabilities$1.09B$1.12B$1.09B$1.05B$1.02B$935M$961M$923M
Total equity$2.99B$2.99B$3.18B$3.05B$2.93B$2.68B$2.68B$2.75B

Implied volatility — last 90 days

23%32%42%52%62% Jun 07 — IV 39% · EM ±5.3%Jun 08 — IV 37% · EM ±4.9%Jun 09 — IV 37% · EM ±4.6%Jun 10 — IV 35% · EM ±4.2%Jun 11 — IV 33% · EM ±3.7%Jun 12 — IV 33% · EM ±3.3%Jun 15 — IV 37% · EM ±2.7%Jun 16 — IV 40% · EM ±2.4%Jun 17 — IV 63% · EM ±2.6%Jun 19 — IV 30% · EM ±6.7%Jun 22 — IV 32% · EM ±6.7%Jun 23 — IV 30% · EM ±6.2%Jun 24 — IV 32% · EM ±6.3%Jun 25 — IV 30% · EM ±5.9%Jun 26 — IV 30% · EM ±5.8%Jun 29 — IV 31% · EM ±5.5%Jun 30 — IV 32% · EM ±5.5%Jul 01 — IV 31% · EM ±5.1%Jul 02 — IV 29% · EM ±4.6%Jul 03 — IV 30% · EM ±4.6%Jul 06 — IV 31% · EM ±4.3%Jul 07 — IV 31% · EM ±4.2%Jul 08 — IV 35% · EM ±4.4%Jul 09 — IV 32% · EM ±3.7%Jul 10 — IV 31% · EM ±3.4%Jul 13 — IV 35% · EM ±2.9%Jul 14 — IV 36% · EM ±2.6%Jul 15 — IV 37% · EM ±2.2%Jul 16 — IV 40% · EM ±1.7%Jul 20 — IV 47% · EM ±11.2%Jul 21 — IV 46% · EM ±10.7%Jul 22 — IV 46% · EM ±10.5%Jul 23 — IV 30% · EM ±6.7%Jul 24 — IV 30% · EM ±6.6%Jul 27 — IV 31% · EM ±6.5%Jul 28 — IV 30% · EM ±6.2%Jul 29 — IV 31% · EM ±6.2%Jul 30 — IV 29% · EM ±5.7%Jul 31 — IV 29% · EM ±5.6%Aug 03 — IV 31% · EM ±5.5%Aug 04 — IV 29% · EM ±5.0%Aug 05 — IV 27% · EM ±4.5%Aug 06 — IV 29% · EM ±4.7%Aug 07 — IV 26% · EM ±4.1%Aug 10 — IV 28% · EM ±3.8%Aug 11 — IV 28% · EM ±3.8%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 26% · EM ±3.0%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 30% · EM ±2.5%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 28% · EM ±1.6%Aug 20 — IV 42% · EM ±1.8%Aug 24 — IV 26% · EM ±5.4%Aug 25 — IV 25% · EM ±5.2%Aug 26 — IV 26% · EM ±5.1%Aug 27 — IV 26% · EM ±5.0%Aug 28 — IV 25% · EM ±4.7%Aug 31 — IV 26% · EM ±4.6%Sep 01 — IV 26% · EM ±4.4%Sep 02 — IV 26% · EM ±4.3%Sep 03 — IV 24% · EM ±3.9%Sep 04 — IV 23% · EM ±3.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in